What people tend to report
Hermansen K, Bkdal TA, Dring M, Pietraszek A, Mortensen LS, Jrgensen H, Flint A: Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
However, self-prescribing is never a good idea
Perraudeau F, McMurdie P, Bullard J, et al
This makes the combination particularly well suited to mechanistic studies of receptor cross-talk, signal amplification, and pulse generation that single-receptor models cannot adequately replicate [2][3]
The oral versus injection comparison for tirzepatide covers these differences in detail